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a  b  s  t  r  a  c  t
Viruses  are  major  contributors  to acute  respiratory  infection-related  morbidity  and  mortality  worldwide.
The inﬂuenza  (IF)  viruses  and  human  respiratory  syncytial  virus  (RSV)  play  a  particularly  important  role in
the  etiology  of acute  respiratory  infections.  This  study  sought  to standardize  a one-step  duplex  real-time
RT-PCR  technique  to  optimize  diagnosis  of  IFA/IFB  and  RSVA/RSVB  infection.  Viral  RNA  was  extracted
with  the  commercially  available  QIAamp  Mini  Kit  according  to manufacturer  instructions.  RT-PCR was
performed  with  primers  to  the  matrix  protein  gene  of IFA, the hemagglutinin  gene  of IFB  and  the N gene
of  RSVA  and  RSVB.  The  limits  of  detection  were  1 copy/L  for IFA,  10  copies/L  for  IFB,  5 copies/L  fornﬂuenza virus
ne-step real-time PCR
olecular diagnostics
olecular epidemiology
RSVA,  and  250 copies/L  for RSVB.  The  speciﬁcity  of  RT-PCR  was  determined  by  comparison  against  a
panel  of  several  respiratory  pathogens.  RT-PCR  and  indirect  immunoﬂuorescence  (IIF)  were compared
in a sample  of  250  nasopharyngeal  aspirates  (NPAs)  collected  during  the  year  2010.  RT-PCR  was  more
sensitive  than  IIF  and able  to detect  viral  co-infections.  In  summary,  RT-PCR  optimized  for  IFA/IFB  and
RSVA/RSVB  is  sensitive  and  speciﬁc  for these  viral  agents  and  is therefore  useful  for  assessment  of  the
fectioetiology  of  respiratory  in
. Introduction
Viruses are major contributors to the morbidity and mortality
f acute respiratory infections worldwide (Fairchok et al., 2010).
mong these viruses, inﬂuenza (IF) and respiratory syncytial
irus (RSV) are some of the most common etiological agents of
espiratory infections. RSV is a well-known cause of lower respi-
atory tract infection in young children (Hall et al., 2009) and is
ow recognized as an increasingly important cause of respiratory
nfection in adults (Falsey et al., 2005; Caram et al., 2009). Inﬂuenza
iruses remain signiﬁcant causes of respiratory infections annually,
espite the availability of vaccines and increasing efforts to achieve
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ucianadesnunes@hotmail.com (L. de Souza Nunes), rkuchen@gmail.com
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targeted vaccination rates (Kehl and Kumar, 2009). Furthermore,
new IF strains have been described recently as etiological viruses
in epidemics (Gatherer, 2009).
Accurate detection of respiratory viruses is important to guide
antiviral therapy, to prevent nosocomial transmission during the
seasonal period of more hospitalizations, and, in some cases,
to decrease the hospital healthcare-associated costs (Kuypers
et al., 2006). From a clinical standpoint, accurate identiﬁcation
of the causative agent of respiratory tract infections is impor-
tant for proper clinical management. The identiﬁcation of viruses
is even more important for epidemiological purposes, such as
the surveillance of respiratory infections during seasonal epi-
demics, assessment of high-risk groups, and allocation of hospital
resources. On the other hand, diagnosis can be problematic, as a
wide range of pathogens can cause acute respiratory infections pre-
senting with similar clinical syndromes. Nucleic acid ampliﬁcation
testing is emerging as the preferred method of diagnostic testing
Open access under the Elsevier OA license.for viral respiratory infections. Real-time technology and the ability
to perform multiplex testing have facilitated the use of this molec-
ular technique to diagnose a variety of respiratory viruses (Panning
et al., 2009; Kehl and Kumar, 2009; Olofsson et al., 2011). This
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study sought to validate a one-step duplex real-time polymerase
chain reaction (RT-PCR) technique with the objective of optimi-
zing diagnosis of IFA/IFB and RSVA/RSVB infection for clinical and
epidemiological purposes.
2. Methods
2.1. Primer and probe design
The sequences of primers and probes, their original studies, and
the results of in silico evaluation are shown in Table 1. RT-PCR was
performed with primers speciﬁc to the matrix protein gene of IFA,
the hemagglutinin of IFB, and the N gene of RSVA and RSVB (Hu
et al., 2003; Schweiger et al., 2000; WHO, 2009).
2.2. RNA extraction and ampliﬁcation conditions
RNA was extracted with the commercially available QIAamp®
Viral RNA Mini Kit (Qiagen, Valencia, CA, USA), according to
manufacturer instructions. Ampliﬁcation was  performed with the
SuperScriptTM III Platinum® One-Step Quantitative RT-PCR System
(Invitrogen, Carlsbad, CA, USA) in a 7500 Real Time PCR cycler
(Applied Biosystems, Foster City, CA, USA). The ampliﬁcation proto-
col was  50 ◦C for 30 min; 95 ◦C for 2 min; and 45 cycles of 94 ◦C, 15 s,
and 55 ◦C, 35 s. Primers (Invitrogen, Carlsbad, CA, USA) at 800 nM
and probes (Applied Biosystems, Foster City, CA, USA) at 200 nM
were used for two different reactions, IFA/IFB ampliﬁcation and
RSVA/RSVB ampliﬁcation. Positive controls included Fluvac® (Inno-
vator EWT, Fort Dodge, IA, USA) for IFA and clinical samples for IFB,
RSVA, and RSVB, which were conﬁrmed by sequencing. Negative
controls (sterilized water) were used in each reaction. In clinical
samples, detection of a human gene (RNase P) was used as the
internal control for the reaction. The reaction volume was 15 L
– 5 L of RNA and 10 L of reagent mix.
Primer and probe sets were tested ﬁrst as a single reaction, then
as two  duplex reactions (RSVA/RSVB and IFA/IFB detection). Sam-
ples were considered positive if the Ct (Cycle threshold) value was
≤45 and the shape of the ampliﬁcation curve was  appropriate. Sam-
ples were considered negative if the internal control (RNAse P) was
positive and there were no characteristic ampliﬁcation curves for
viral targets.
2.3. Limit of detection and assay speciﬁcity
Analytical sensitivity (limit of detection, LOD) was established
by quantitative evaluation of the ampliﬁcation products of posi-
tive controls. These ampliﬁcations were puriﬁed by ExoSAP-IT (USB
Corporation, Cleveland, OH, USA) and quantiﬁed in a NanodropTM
1000 spectrophotometer (Thermo Fisher Scientiﬁc, Wilmington,
DE, USA). The number of copies of each control was obtained and
serial dilutions (from 1 to 105 copies/L) were used to determine
the LOD. LOD assays were performed in duplicate for separate and
duplex reactions.
Speciﬁcity assays were performed using a set of ampliﬁca-
tion products of clinical isolates with positive results for different
respiratory pathogens (Bordetella pertussis, Bordetella paraper-
tussis, Enterovirus, Adenovirus,  Cytomegalovirus, Mycobacterium
tuberculosis, Haemophilus inﬂuenzae,  Herpes simplex, Streptococ-
cus pneumoniae, Pneumocystis jiroveci, Chlamydia pneumoniae, RSV,
Parainﬂuenza-1, Parainﬂuenza-2, Parainﬂuenza-3, and Epstein-
Barr virus).2.4. Patient samples
Nasopharyngeal aspirate (NPA) specimens were collected in
phosphate-buffered saline (PBS) and frozen at −80 ◦C, followed by
F. de-Paris et al. / Journal of Virological Methods 186 (2012) 189– 192 191
Table  2
Results from 250 NPA samples.
Samples (n = 250) IIF RSV IIF IFB RT-PCR RSVA RT-PCR RSVB RT-PCR IFB
112 (44.8%) − − − − −
64 (25.6%) + − + − −
35 (14%) − − + − −
11  (4.4%) + − − + −
11  (4.4%) − − − + −
5  (2%) + − − − −
3  (1.2%) + − + + −
3 (1.2%) − + − − +
2 (0.8%) − − + − +
2 (0.8%) + − + − +
1  (0.4%) + − − − +
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IF, immunoﬂuorescence; RT-PCR, one step duplex RT-PCR; −, negative; +, positive.
NA extraction and RT-PCR ampliﬁcation. This study included 250
PAs collected between May  and September 2010 and previously
ested for respiratory viruses by a commercially available indi-
ect immunoﬂuorescence (IIF) assay (Medivax®, Dublin, Ireland).
 comparison between RT-PCR and IIF could thus be established.
ll NPAs had been obtained for clinical purposes as part of standard
are. The study protocol was approved by the Institutional Review
oard of Hospital de Clínicas de Porto Alegre.
. Results
In silico coverage of the selected oligonucleotides was >98%
Table 1). This coverage rate was considerate adequate for use of
his set of probes and primers.
The positive controls showed adequate results (Ct <20) in both
rotocol conditions (single and duplex reaction). The LOD was
 copy/L for IFA, 10 copies/L for IFB, 5 copies/L for RSVA, and
50 copies/L for RSVB. These LODs were similar in separate and
uplex reactions. LOD data showed a Poisson distribution and the
orresponding obtained Cts showed linearity (data not shown).
All tests for different respiratory pathogens had negative results,
hich show an absence of cross-reactivity between RT-PCR and this
anel.
Of the tested samples, 51.2% (128/250) were positive for RSV by
T-PCR, while only 34.3% (86/250) were positive by IIF. Further-
ore, 3.6% (9/250) were positive for IFB by RT-PCR, while only 1.2%
3/250) were positive by IIF. No samples were positive for IFA with
ither technique. Among the clinical specimens positives, 89.7%
howed Ct values between cycles 12 and 39.
In this study, IIF failed to detect RSV in 46 samples (35 for
SVA and 11 for RSVB) as compared with RT-PCR. RT-PCR failed
o detect RSV in only ﬁve samples when compared with IIF. All
hree samples that tested positive for IFB on IIF were detected by
T-PCR. Furthermore, IIF did not detect IFB in six samples when
ompared with RT-PCR (Table 2). It should be noted that RT-PCR
as able to detected co-infection (three RSVA/RSVB co-infections
nd four RSVA/IFB co-infections), whereas the IIF technique was
ot (Table 2).
. Discussion
The aim of this study was the optimizing of a one-step duplex
T-PCR technique for IFA/IFB and RSVA/RSVB detection. Primers
nd probes were adapted from different protocols (Table 1) to
stablish a single assay with the same extraction and ampliﬁcation
onditions. This optimized assay proved speciﬁc for the viruses of
nterest, as no cross-reaction against a panel of other respiratory
athogens was detected. Furthermore, this assay exhibited high
nalytical sensitivity, being able to detect as low as 1 copy/L of− − +
IFA, 10 copies/L of IFB, 5 copies/L of RSVA, and 250 copies/L of
RSVB.
The results of this study demonstrated that protocol performed
well on clinical samples, resulting in an increasing the detection
of IFB and RSVA/RSVB in NPA specimens. The IIF assay detected
89 samples (35.6%) and RT-PCR detected 133 (53.2%), thus prov-
ing the higher sensitivity of RT-PCR assay as compared with IIF.
This increased sensitivity could be explained by the ability of PCR
methods to detect lower viral loads in clinical samples, as pre-
viously reported by Kuypers et al. (2006),  who  showed that the
mean number of viral copies per mL  in specimens positive on
both PCR and IIF was signiﬁcantly higher (107) than that of speci-
mens positive only on PCR (104). This suggests that PCR is suitable
for detection of respiratory viruses in samples from adults which
often exhibit lower viral loads than samples obtained from children
(Kuypers et al., 2006). Furthermore, it is known that probability
of detection of respiratory viruses increases with the duration of
symptoms. Patients presenting within 0–6 days of symptom from
the onset exhibit less viral shedding than those tested 7–14 days
after symptoms arise (Brittain-Long et al., 2010; Olofsson et al.,
2011). Therefore, this optimized RT-PCR technique could improve
the possibility of viral detection in samples collected longer after
the onset of symptoms.
In addition, it bears stressing that all samples testing positive for
IFB on IIF were detected by RT-PCR, and only ﬁve samples positive
for RSV on IIF were not detected by RT-PCR. Remarkably, none of
the specimens used in this study were positive for IFA by either
method. This was most likely due to the extensive immunization
campaign against inﬂuenza A/H1N1 and other seasonal inﬂuenza
strains that was carried out worldwide, including in Brazil, in 2010.
Another important aspect of optimized RT-PCR is that this tech-
nique can be performed with frozen samples, unlike IIF, which
requires fresh specimens. In a previous study, respiratory viruses
were detected by PCR in 25% of specimens judged inadequate for
IIF analysis (Kuypers et al., 2006).
Concerning viral co-infection, seven cases were found in this
study (three co-infections with RSVA and RSVB and four co-
infections with RSVA and IFB) by RT-PCR; none was detected with
the IIF technique. Several studies have acknowledged the possi-
bility of multiple infections in viral respiratory diseases detected
by molecular methods (Kuypers et al., 2006; Paranhos-Baccalà
et al., 2008). Furthermore, multiple respiratory viruses have been
detected in approximately 10% of respiratory specimens, with
higher rates recorded in samples from young children and immuno-
suppressed patients (Olofsson et al., 2011). Some authors suggest
an association between dual infections and increased disease sever-
ity (Richard et al., 2008; Paranhos-Baccalà et al., 2008; Olofsson
et al., 2011). Indeed, the clinical and epidemiological signiﬁcance of
co-infections is uncertain, but infection with multiple viruses can
only be detected with the use of molecular techniques. Notably,
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he optimized RT-PCR protocol described herein was  able to detect
SVA and RSVB separately, which may  be very useful for studies
ith epidemiological purposes.
Furthermore, this study has considered that the real time PCR
echnique is suitable for limited multiplexing. This technique is
lso excellent for in-house testing, providing an affordable analysis
apability for the outpatient clinic (Olofsson et al., 2011). Therefore,
his RT-PCR technique could be feasible and more cost-effective for
outine clinical than a multiplex 15-virus panel or other extended
olecular diagnostics.
In summary, the one-step duplex RT-PCR technique optimized
or IFA/IFB and RSVA/RSVB described herein is suitable for the clini-
al laboratory setting, requiring only one RNA extraction and using
he same ampliﬁcation conditions as used for multiple virus detec-
ion, as well as internal controls. It is less labor-intensive than IIF
nd exhibited reliable sensitivity and speciﬁcity, making it use-
ul for establishment of the etiology of respiratory infections for
linical and epidemiological purposes alike.
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